Vident Advisory LLC Lowers Stake in Axcelis Technologies, Inc. $ACLS

Key Points

• Vident Advisory LLC has reduced its stake in Axcelis Technologies by 46.5%, owning 18,957 shares worth approximately $942,000 after selling 16,453 shares.
• In contrast, several other hedge funds, including Vanguard Group and Reinhart Partners, have increased their holdings in Axcelis, reflecting a mixed sentiment among institutional investors.
• Axcelis Technologies reported $1.13 earnings per share (EPS) for its latest quarter, surpassing consensus estimates of $0.73, despite a 24.2% decline in revenue compared to the previous year.

Vident Advisory LLC trimmed its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 46.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,957 shares of the semiconductor company's stock after selling 16,453 shares during the period. Vident Advisory LLC owned 0.06% of Axcelis Technologies worth $942,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of ACLS. Vanguard Group Inc. raised its stake in shares of Axcelis Technologies by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 4,439,902 shares of the semiconductor company's stock valued at $220,530,000 after purchasing an additional 43,768 shares during the period. Reinhart Partners LLC. raised its holdings in Axcelis Technologies by 39.1% in the 1st quarter. Reinhart Partners LLC. now owns 1,441,022 shares of the semiconductor company's stock valued at $71,576,000 after acquiring an additional 404,910 shares during the period. American Century Companies Inc. lifted its holdings in Axcelis Technologies by 7.6% during the 1st quarter. American Century Companies Inc. now owns 1,140,495 shares of the semiconductor company's stock worth $56,648,000 after purchasing an additional 80,399 shares during the last quarter. Boston Trust Walden Corp boosted its position in shares of Axcelis Technologies by 0.8% in the first quarter. Boston Trust Walden Corp now owns 826,332 shares of the semiconductor company's stock valued at $41,044,000 after acquiring an additional 6,216 shares during the period. Finally, BlackBarn Capital Partners LP grew its position in shares of Axcelis Technologies by 758.0% during the 1st quarter. BlackBarn Capital Partners LP now owns 480,441 shares of the semiconductor company's stock worth $23,864,000 after purchasing an additional 424,444 shares in the last quarter. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently commented on ACLS shares. B. Riley increased their target price on shares of Axcelis Technologies from $58.00 to $75.00 and gave the stock a "neutral" rating in a report on Wednesday, June 18th. DA Davidson upped their target price on Axcelis Technologies from $75.00 to $90.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Two investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $90.00.

Axcelis Technologies Stock Performance

ACLS stock traded up $0.20 during mid-day trading on Wednesday, hitting $83.28. The company had a trading volume of 300,367 shares, compared to its average volume of 427,818. Axcelis Technologies, Inc. has a 12 month low of $40.40 and a 12 month high of $110.17. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.26 and a current ratio of 6.01. The stock's fifty day moving average price is $76.87 and its two-hundred day moving average price is $63.95. The firm has a market cap of $2.62 billion, a PE ratio of 17.03 and a beta of 1.73.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last posted its earnings results on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share for the quarter, beating analysts' consensus estimates of $0.73 by $0.40. Axcelis Technologies had a return on equity of 16.26% and a net margin of 17.69%.The business had revenue of $194.54 million during the quarter, compared to analyst estimates of $185.15 million. During the same quarter in the previous year, the firm earned $1.55 EPS. The company's quarterly revenue was down 24.2% compared to the same quarter last year. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. On average, analysts forecast that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current fiscal year.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.